ShiftPixy (NASDAQ: PIXY) is changing the way we work in the new gig economy
FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis
Article Link: FDA Approves Kesimpta (ofatumumab) Targeted B-cell Therapy for Patients with Relapsing Multiple Sclerosis Basel, August 20,...
FDA Approves New Kyprolis (carfilzomib) Combination Regimen with Darzalex (daratumumab) and Dexamethasone in Both Once- And Twice-Weekly Dosing Regimens
Article Link: FDA Approves New Kyprolis (carfilzomib) Combination Regimen with Darzalex (daratumumab) and Dexamethasone in Both Once- And Twice-Weekly...
FDA Approves Enspryng (satralizumab-mwge) for Neuromyelitis Optica Spectrum Disorder
Article Link: FDA Approves Enspryng (satralizumab-mwge) for Neuromyelitis Optica Spectrum Disorder South San Francisco, CA — August...
Our March 24th, 2020 Report US Gold Corp. at $3.37/share Now up Nearly 300% Acquisition Announced
US Gold (USAU) Breaking News on Acquisition How High Can Gold Prices Go? Up nearly 300% since our March report – https://mailchi.mp/tradersnewss...
FDA Approves Viltepso (viltolarsen) for the Treatment of Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy
Article Link: FDA Approves Viltepso (viltolarsen) for the Treatment of Duchenne Muscular Dystrophy in Patients Amenable to Exon 53 Skipping Therapy...
FDA Approves Olinvyk (oliceridine) Injection for the Management of Severe Acute Pain
Article Link: FDA Approves Olinvyk (oliceridine) Injection for the Management of Severe Acute Pain CHESTERBROOK, Pa., Aug. 10, 2020 (GLOB...
FDA Approves Evrysdi (risdiplam) for Treatment of Spinal Muscular Atrophy (SMA) in Adults and Children 2 Months and Older
Article Link: FDA Approves Evrysdi (risdiplam) for Treatment of Spinal Muscular Atrophy (SMA) in Adults and Children 2 Months and Older S...
We are Initiating Coverage on JanOne Inc. (NASDAQ: JAN), a Biotech Company with a Lead Product to Combat Covid-19
Traders News Source Initiates Coverage on JanOne Inc. (NASDAQ: JAN), a Biotech Company with a Lead Product to Combat Covid-19
FDA Approves Lampit (nifurtimox) for the Treatment of Chagas Disease in Children
Article Link: FDA Approves Lampit (nifurtimox) for the Treatment of Chagas Disease in Children WHIPPANY, N.J.–(BUSINESS WIRE) Augus...